Vapiprost Hydrochloride-impurities | Pharmaffiliates

vapiprost hydrochloride and its Impurities

vapiprost hydrochloride events and occlusive vascular disease. Phase III trials were underway in Japan for the treatment of deep vein thrombosis. Reference standards of Vapiprost Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 1 results for vapiprost hydrochloride Impurities
PA 22 16000

Vapiprost Hydrochloride - API Standards

Vapiprost Hydrochloride


  • Catalogue No.:PA 22 16000

  • CAS :

    87248-13-3

  • Molecular Formula : C30H40ClNO4

  • Molecular Weight : 514.10